SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

Trial Identifier: D4193R00002
Sponsor: AstraZeneca
NCTID:: NCT02543476
Start Date: September 2015
Primary Completion Date: November 2016
Study Completion Date: November 2016
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Germany, Sachsen Leipzig, Sachsen, Germany
Greece, Athens Athens, Greece
Italy, Milano Milano, Italy
Italy, Verona Legnago (VR), Verona, Italy
Japan, Osaka-Fu Osaka-shi, Osaka-Fu, Japan
Japan, Tokyo-To Koto-ku, Tokyo-To, Japan
Korea, Republic of, Seoul Seoul, Korea, Republic of
Spain, Barcelona Barcelona, Spain
Spain, Sevilla Sevilla, Spain
United States, California La Jolla, California, United States
United States, Georgia Atlanta, Georgia, United States
United States, Maryland Hyattsville, Maryland, United States
United States, Massachusetts Boston, Massachusetts, United States
United States, North Carolina Charlotte, North Carolina, United States
United States, Oregon Portland, Oregon, United States
United States, South Dakota Sioux Falls, South Dakota, United States
United States, Tennessee Nashville, Tennessee, United States
United States, Texas Houston, Texas, United States